Skip to content

IV Administration

by Hospira, Inc.

510(k) K142622

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

1 ongoing

This device is named in the recall

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK142622 Date15 Jan 2015ClearedStatusActive

Official records

From the FDA record

Received by the FDA
16 Sep 2014
FDA decision
15 Jan 2015 (Substantially Equivalent)
FDA review time
121 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K142622 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Recalls

1 recall · 1 ongoing · FDA

    • Ongoing Z-3160-2026 FDA Class II initiated 12 May 2026

    Intravascular administration tubing set drip chambers may have black specks potentially due to the plastic molding process leaving discolored polyvinyl chloride (PVC) material within the drip chamber wall. The presence of discoloration and particulate matter in the fluid path has not been ruled out.

Timeline

2 dated events

  1. Cleared FDA 510(k) K142622
  2. Recall initiated FDA recalls Z-3160-2026

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
FPA
Device class
Class II
Regulation
21 CFR Part 880.5440
Advisory committee
General Hospital
FDA decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is classified as an Intravenous Administration Set (FDA Product Code: FPA), designed for the controlled delivery of fluids, medications, or nutrients directly into a patient’s venous system. It facilitates precise infusion rates and ensures compatibility with single-fluid regimens via intravenous, subcutaneous, or arterial routes, supporting a range of clinical applications including patient-controlled analgesia (PCA) when configured with appropriate accessories.

The IV Administration Set is supplied as a single-use, non-sterile device (unless specified otherwise in sterile packaging) and is intended for use in hospital or clinical settings. It is regulated under FDA 510(k) clearance (K142622) as substantially equivalent to predicate devices, with no explicit MRI safety classification noted. Storage and handling follow standard aseptic practices, and its design adheres to general hospital use guidelines as per the HO Advisory Committee review. No additional regulatory markings beyond the FDA clearance are provided in the specifications.

Similar devices

Other devices filed under FDA product code FPA (Set, Administration, Intravascular).

Other devices from Hospira, Inc.

See all devices from Hospira, Inc. →